Ascendis Pharma (ASND) – Analyst EPS View
-
Ascendis Pharma (ASND) PT Raised to $75 at JPMorgan; 'Pipeline Updates Increase Our Confidence'
-
Ascendis Pharma (ASND) PT Raised to $34 at Wedbush Following FY16 Results; 'Pipeline Progress on Multiple Fronts'
Back to ASND Stock Lookup